SynthesisFrontiers in pharmacology2023

Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials.

Yue Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.